US FDA approves Ardelyx's kidney disease-related drug

Ardelyx

18/10/2023 24:06

Oct 17 (Reuters) - The U.S. Food and Drug Administration
(FDA) has approved  Ardelyx's  ARDX.O  drug to treat high
phosphate levels in patients with chronic kidney disease (CKD),
the company said on Tuesday, more than two years after it was
initially rejected.
    

 (Reporting by Mariam Sunny, Khushi Mandowara and Leroy Leo in
Bengaluru; Editing by Shinjini Ganguli)
 ((Mariam.ESunny@thomsonreuters.com;))